CVD biomarkers respond better to Telmisartan than non-ARB blood pressure meds
When it comes to treating high blood pressure, not all anti-hypertensive medications are equal, and results of the ATTEMPT-CVD trial suggest that telmisartan, an angiotensin II receptor blocker (ARB) might have benefits over ...
Aug 31, 2015
0
6